+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Symptom relief in gastroesophageal reflux disease (GERD): pantoprazole V nizatidine in a mixed patient population with endoscopy negative reflux disease (ENRD) and erosive esophagitis (EE)



Symptom relief in gastroesophageal reflux disease (GERD): pantoprazole V nizatidine in a mixed patient population with endoscopy negative reflux disease (ENRD) and erosive esophagitis (EE)



American Journal of Gastroenterology 95(9): 2411-2411




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062932839

Download citation: RISBibTeXText

DOI: 10.1111/j.1572-0241.2000.02360.x


Related references

Symptom relief in gastroesophageal reflux disease Pantoprazole V nizatidine in a mixed patient population with endoscopy negative reflux disease and erosive esophagitis. American Journal of Gastroenterology 95(9): 2411, 2000

Symptom relief in gastroesophageal reflux disease: A randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. American Journal of Gastroenterology 96(10): 2849-2857, 2001

Pantoprazole heals erosive esophagitis more effectively and provides greater symptomatic relief than placebo or nizatidine in gastroesophageal reflux disease patients. Gastroenterology 116(4 Part 2): A125, 1999

Pantoprazole treatment of erosive esophagitis (EE) in gastroesophageal reflux disease (GERD) patients maintains median serum gastrin levels within the normal range. American Journal of Gastroenterology 95(9): 2428-2428, 2000

Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clinical Pediatrics 45(8): 741-749, 2006

Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World Journal of Gastroenterology 13(45): 6009-6015, 2007

Risk factors for low response to proton-pump inhibitor treatment in reflux esophagitis and non-erosive reflux disease evaluated by the frequency scale for the symptoms of gastroesophageal reflux disease. Esophagus 12(3): 225-232, 2015

Severity of gastroesophageal reflux disease (GERD) symptoms and erosive esophagitis (EE) as a function of age. American Journal of Gastroenterology 98: S6-S7, 2003

Predictors of erosive esophagitis in patients with symptoms of gastroesophageal reflux disease (GERD). American Journal of Gastroenterology 102(Suppl. 2): S136-S137, 2007

Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group. Journal of Neurogastroenterology and Motility 20(1): 64-73, 2014

W1842 Increasing Severity of Reflux Esophagitis (Re) Among Young Patients with Gastroesophageal Reflux Disease (Gerd) in Chinese Population: A 10-Year Prospective Study. Gastroenterology 136(5): A-737, 2009

T1694 Characteristics of Asymptomatic Gastroesophageal Reflux Disease (Gerd) and Association With Lifestyle Factors Asymptomatic Gerd vs. Non-Erosive Reflux Disease (Nerd). Gastroenterology 138(5): S-559, 2010

Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group. Digestive Diseases and Sciences 37(6): 865-874, 1992

Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Digestive Diseases and Sciences 51(9): 1595-1601, 2006

S1908 Symptom Association Probability for Acid and Nonacid Reflux in Patients with Erosive Esophagitis (Ee) and Non-Erosive Reflux Disease (Nerd). Gastroenterology 136(5): A-290, 2009